What does Cipla do?
Cipla Limited is a prominent Indian pharmaceutical company that manufactures and markets a variety of branded and generic drugs and Active Pharmaceutical Ingredients (APIs). As of March 2025, it reported net sales of ₹6,730 Cr and a net profit of ₹1,222 Cr, with a market cap of ₹121,226 Cr.
Overview: Cipla Limited is a leading pharmaceutical company in India, engaged in the manufacturing, developing, and marketing of a wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs) within the Pharmaceuticals & Biotechnology industry.History:
Cipla was incorporated in the year 1935. The latest quarterly results reported are for March 2025, showing net sales and profit figures.
Financial Snapshot:
Net Sales: 6,730 Cr (Quarterly Results - Mar 2025)
Net Profit: 1,222 Cr (Quarterly Results - Mar 2025)
Market Cap: Rs 121,226 Cr (Large Cap)
Key Metrics:
P/E: 23.00
Industry P/E: 35
Dividend Yield: 0.87%
Debt-Equity: -0.25
Return on Equity: 16.90%
Price to Book: 3.86
Contact Details:
Address: Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel Mumbai Maharashtra : 400013
Tel: 91-22-24826000
Email: cosecretary@cipla.com
Website: http://www.cipla.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
